InvestLog
KNSA logo

KNSA

Kiniksa Pharmaceuticals, Ltd.NASDAQHealthcare
$48.82+1.50%ClosedMarket Cap: $3.62B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-02-25Wells Fargo—Overweight—
2026-02-25Wedbush—Outperform—
2026-01-13Wedbush—Outperform—
2025-10-29Goldman Sachs—Buy—
2025-10-17Citigroup—Buy—
2025-10-13Wedbush—Outperform—
2025-09-25Wells Fargo—Overweight—
2025-07-29Jefferies—Buy—
2025-07-09Wells Fargo—Overweight—
2025-04-29Jefferies—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$1.61$1.08B5
Sun Dec 31$2.26$1.24B6
Mon Dec 31$2.80$1.35B4
Tue Dec 31$4.42$1.51B2